Found: 161
Select item for more details and to access through your institution.
Neighborhood disadvantage is associated with KRAS-mutated non-small cell lung cancer risk.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 8, p. 5231, doi. 10.1007/s00432-022-04455-7
- By:
- Publication type:
- Article
FYN is overexpressed in human prostate cancer.
- Published in:
- BJU International, 2009, v. 103, n. 2, p. 171, doi. 10.1111/j.1464-410X.2008.08009.x
- By:
- Publication type:
- Article
HABP2 is a novel regulator of hyaluronan-mediated human lung cancer progression.
- Published in:
- Frontiers in Oncology, 2015, p. 1, doi. 10.3389/fonc.2015.00164
- By:
- Publication type:
- Article
A cdc15-like adaptor protein (CD2BP1) interacts with the CD2 cytoplasmic domain and regulates CD2-triggered adhesion.
- Published in:
- EMBO Journal, 1998, v. 17, n. 24, p. 7320, doi. 10.1093/emboj/17.24.7320
- By:
- Publication type:
- Article
Effective osimertinib treatment in a patient with discordant T790 M mutation detection between liquid biopsy and tissue biopsy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Integrating Clinical and Translational Research Networks—Building Team Medicine.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Small Cell Lung Cancer from Traditional to Innovative Therapeutics: Building a Comprehensive Network to Optimize Clinical and Translational Research.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 8, p. 2433, doi. 10.3390/jcm9082433
- By:
- Publication type:
- Article
Complex Oncological Decision-Making Utilizing Fast-and-Frugal Trees in a Community Setting—Role of Academic and Hybrid Modeling.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 6, p. 1884, doi. 10.3390/jcm9061884
- By:
- Publication type:
- Article
Non-Small Cell Lung Cancer from Genomics to Therapeutics: A Framework for Community Practice Integration to Arrive at Personalized Therapy Strategies.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 6, p. 1870, doi. 10.3390/jcm9061870
- By:
- Publication type:
- Article
Implementing Lung Cancer Screening and Prevention in Academic Centers, Affiliated Network Offices and Collaborating Care Sites.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 6, p. 1820, doi. 10.3390/jcm9061820
- By:
- Publication type:
- Article
Phenotypic Switching of Naïve T Cells to Immune-Suppressive Treg-Like Cells by Mutant KRAS.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 10, p. 1726, doi. 10.3390/jcm8101726
- By:
- Publication type:
- Article
Monitoring and Determining Mitochondrial Network Parameters in Live Lung Cancer Cells.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 10, p. 1723, doi. 10.3390/jcm8101723
- By:
- Publication type:
- Article
Small Cell Lung Cancer Therapeutic Responses Through Fractal Measurements: From Radiology to Mitochondrial Biology.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 10, p. 1038, doi. 10.3390/jcm8071038
- By:
- Publication type:
- Article
Small Cell Lung Cancer Therapeutic Responses Through Fractal Measurements: From Radiology to Mitochondrial Biology.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 7, p. 1038, doi. 10.3390/jcm8071038
- By:
- Publication type:
- Article
Prostate-Associated Gene 4 (PAGE4): Leveraging the Conformational Dynamics of a Dancing Protein Cloud as a Therapeutic Target.
- Published in:
- Journal of Clinical Medicine, 2018, v. 7, n. 6, p. 156, doi. 10.3390/jcm7060156
- By:
- Publication type:
- Article
The gut microbiome and response to immune checkpoint inhibitors: preclinical and clinical strategies.
- Published in:
- Clinical & Translational Medicine, 2019, v. 8, n. 1, p. 1, doi. 10.1186/s40169-019-0225-x
- By:
- Publication type:
- Article
The gut microbiome and response to immune checkpoint inhibitors: preclinical and clinical strategies.
- Published in:
- Clinical & Translational Medicine, 2019, v. 8, n. 1, p. 1, doi. 10.1186/s40169-019-0225-x
- By:
- Publication type:
- Article
Combination systemic therapies with immune checkpoint inhibitors in pancreatic cancer: overcoming resistance to single‐agent checkpoint blockade.
- Published in:
- Clinical & Translational Medicine, 2018, v. 7, n. 1, p. 1, doi. 10.1186/s40169-018-0210-9
- By:
- Publication type:
- Article
Combination systemic therapies with immune checkpoint inhibitors in pancreatic cancer: overcoming resistance to single-agent checkpoint blockade.
- Published in:
- Clinical & Translational Medicine, 2018, v. 7, n. 1, p. 1, doi. 10.1186/s40169-018-0210-9
- By:
- Publication type:
- Article
Evolution of core archetypal phenotypes in progressive high grade serous ovarian cancer.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-23171-3
- By:
- Publication type:
- Article
The receptor tyrosine kinase AXL mediates nuclear translocation of the epidermal growth factor receptor.
- Published in:
- Science Signaling, 2017, v. 10, n. 460, p. 1, doi. 10.1126/scisignal.aag1064
- By:
- Publication type:
- Article
Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy.
- Published in:
- Molecular Cancer, 2014, v. 13, p. 1, doi. 10.1186/1476-4598-13-242
- By:
- Publication type:
- Article
Prognostic and predictive value of circulating tumor cells and CXCR4 expression as biomarkers for a CXCR4 peptide antagonist in combination with carboplatin-etoposide in small cell lung cancer: exploratory analysis of a phase II study.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 3, p. 334, doi. 10.1007/s10637-017-0446-z
- By:
- Publication type:
- Article
Biomarker discovery in lung cancer-promises and challenges of clinical proteomics.
- Published in:
- Mass Spectrometry Reviews, 2007, v. 26, n. 3, p. 451, doi. 10.1002/mas.20125
- By:
- Publication type:
- Article
Near-Complete Response to Combined Pembrolizumab and Platinum-Doublet in a Patient With STK11/KRAS Mutated Advanced Lung Adenocarcinoma.
- Published in:
- Clinical Lung Cancer, 2022, v. 23, n. 2, p. e137, doi. 10.1016/j.cllc.2021.07.007
- By:
- Publication type:
- Article
Improved Survival Outcomes in Medically Fit Patients With Early-Stage Non–Small-Cell Lung Cancer Undergoing Stereotactic Body Radiotherapy.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 5, p. e678, doi. 10.1016/j.cllc.2021.01.003
- By:
- Publication type:
- Article
Therapeutic Potential of Olaparib in Combination With Pembrolizumab in a Young Patient With a Maternally Inherited BRCA2 Germline Variant: A Research Report.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 5, p. e703, doi. 10.1016/j.cllc.2021.01.009
- By:
- Publication type:
- Article
The Effects of Time to Treatment Initiation for Patients With Non-small-cell Lung Cancer in the United States.
- Published in:
- 2021
- By:
- Publication type:
- journal article
PI3 Kinase Pathway and MET Inhibition is Efficacious in Malignant Pleural Mesothelioma.
- Published in:
- Scientific Reports, 2016, p. 32992, doi. 10.1038/srep32992
- By:
- Publication type:
- Article
Unique fractal evaluation and therapeutic implications of mitochondrial morphology in malignant mesothelioma.
- Published in:
- Scientific Reports, 2016, p. 24578, doi. 10.1038/srep24578
- By:
- Publication type:
- Article
Novel Therapeutic Targets and Immune Dysfunction in Malignant Pleural Mesothelioma.
- Published in:
- Frontiers in Pharmacology, 2022, v. 12, p. 1, doi. 10.3389/fphar.2021.806570
- By:
- Publication type:
- Article
MET and PI3K/mTOR as a Potential Combinatorial Therapeutic Target in Malignant Pleural Mesothelioma.
- Published in:
- PLoS ONE, 2014, v. 9, n. 9, p. 1, doi. 10.1371/journal.pone.0105919
- By:
- Publication type:
- Article
The Mu Opioid Receptor Promotes Opioid and Growth Factor-Induced Proliferation, Migration and Epithelial Mesenchymal Transition (EMT) in Human Lung Cancer.
- Published in:
- PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0091577
- By:
- Publication type:
- Article
Activating the Expression of Human K-ras<sup>G12D</sup> Stimulates Oncogenic Transformation in Transgenic Goat Fetal Fibroblast Cells.
- Published in:
- PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0090059
- By:
- Publication type:
- Article
The EphB4 Receptor Tyrosine Kinase Promotes Lung Cancer Growth: A Potential Novel Therapeutic Target.
- Published in:
- PLoS ONE, 2013, v. 8, n. 7, p. 1, doi. 10.1371/journal.pone.0067668
- By:
- Publication type:
- Article
Sphingosine Kinase 1 Is Required for Mesothelioma Cell Proliferation: Role of Histone Acetylation.
- Published in:
- PLoS ONE, 2012, v. 7, n. 9, p. 1, doi. 10.1371/journal.pone.0045330
- By:
- Publication type:
- Article
A Novel Classification of Lung Cancer into Molecular Subtypes.
- Published in:
- PLoS ONE, 2012, v. 7, n. 2, p. 1, doi. 10.1371/journal.pone.0031906
- By:
- Publication type:
- Article
CBL Is Frequently Altered in Lung Cancers: Its Relationship to Mutations in MET and EGFR Tyrosine Kinases.
- Published in:
- PLoS ONE, 2010, v. 5, n. 1, p. 1, doi. 10.1371/journal.pone.0008972
- By:
- Publication type:
- Article
c-Met and hepatocyte growth factor: Potential as novel targets in cancer therapy.
- Published in:
- Current Oncology Reports, 2007, v. 9, n. 2, p. 102, doi. 10.1007/s11912-007-0005-4
- By:
- Publication type:
- Article
Post-crizotinib management of effective ceritinib therapy in a patient with ALK-positive non-small cell lung cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
MicroRNA-1 attenuates the growth and metastasis of small cell lung cancer through CXCR4/FOXM1/RRM2 axis.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-022-01695-6
- By:
- Publication type:
- Article
Increasing clinician participation in tobacco cessation by an implementation science-based tobacco cessation champion program.
- Published in:
- Cancer Causes & Control, 2023, v. 34, n. 1, p. 81, doi. 10.1007/s10552-022-01619-1
- By:
- Publication type:
- Article
Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case series.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 10, p. 1, doi. 10.1007/s00262-024-03775-6
- By:
- Publication type:
- Article
Phenotypic Plasticity and Cancer: A System Biology Perspective.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 15, p. 4302, doi. 10.3390/jcm13154302
- By:
- Publication type:
- Article
Advances in Non-Small Cell Lung Cancer: Current Insights and Future Directions.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 14, p. 4189, doi. 10.3390/jcm13144189
- By:
- Publication type:
- Article
Nanoengineering Solutions for Cancer Therapy: Bridging the Gap between Clinical Practice and Translational Research.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 12, p. 3466, doi. 10.3390/jcm13123466
- By:
- Publication type:
- Article
Leveraging Cancer Phenotypic Plasticity for Novel Treatment Strategies.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 11, p. 3337, doi. 10.3390/jcm13113337
- By:
- Publication type:
- Article
On the Virtues of "Team Medicine"—A City of Hope Perspective.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 15, p. 4897, doi. 10.3390/jcm12154897
- By:
- Publication type:
- Article
Clinical Network Systems Biology: Traversing the Cancer Multiverse.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 13, p. 4535, doi. 10.3390/jcm12134535
- By:
- Publication type:
- Article